The D1 agonist dihydrexidine releases acetylcholine and improves cognition in rats

Annals of the New York Academy of Sciences

Volumn 777, Issue , 1996, Pages 427-430

  Steele, T D ^a   Hodges Jr , D B ^a   Levesque, T R ^a   Locke, K W ^a   Sandage Jr , B W ^a  

^a Interneuron Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLCHOLINE; DIHYDREXIDINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; SCOPOLAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; PHENANTHRIDINE DERIVATIVE;

ACETYLCHOLINE BRAIN LEVEL; ACETYLCHOLINE RELEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DEMENTIA; DRUG EFFECT; DRUG EFFICACY; FRONTAL CORTEX; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; MALE; MEMORY; MICRODIALYSIS; NONHUMAN; RAT; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; FRONTAL LOBE; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALIA;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ACETYLCHOLINE; AMNESIA; ANIMALS; COGNITION; CORPUS STRIATUM; DOPAMINE AGONISTS; FRONTAL LOBE; MALE; PHENANTHRIDINES; RATS; RATS, SPRAGUE-DAWLEY; SCOPOLAMINE;

EID: 0029664581     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb34457.x     Document Type: Conference Paper

References (14)

1. KEBABIAN, J. W. & D. B. CALNE. 1979. Nature 277:93-96.
2. MOTTOLA, D. M., W. K. BREWSTER, L. L. COOK, D. E. NICHOLS & R. B. MAILMAN. 1992. J. Pharmacol. Exp. Therap, 262:383-393.
3. BREWSTER, W. K., D. E. NICHOLS, R. M. RIGGS, D. M. MOTTOLA, T. W. LOVENBERG, M. H. LEWIS & R. B. MAILMAN. 1990. J. Med. Chem. 33: 1756-1764.
4. TAYLOR, J. R., M. S. LAWRENCE, D. E. REDMOND, J. D. ELSWORTH, R. H. ROTH, D. E. NICHOLS & R. B. MAILMAN. 1991. Eur. J. Pharmacol. 199: 389-391.
5. SPICER, M. A., J. D. ELSWORTH, M. S. LAWRENCE, R. H. ROTH, J. R. TAYLOR, R. B. MAILMAN, D. E. NICHOLS & D. E. REDMOND. 1993. 1st International Meeting on Dopamine Agonists (abstract).
6. BERTORELLI, R. & S. CONSOLO. 1990. J. Neurochem. 54:2145-2148.
7. WHITEHOUSE, P. J., D. L. PRICE, R. G. STRUBLE, A. W. CLARK, J. T. COYLE & M. R. DELONG. 1982. Science 215:1237-1239.
8. BARTUS, R. T., R. L. DEAN, B. BEER, & A. S. LIPPA. 1982. Science 217: 408-417.
9. WHITEHOUSE, P. J. & J. R. UNGERSTADT. 1988. Eur. Neurol. 28(Suppl. 1): 36-41.
10. DAMSMA, G., G. S. ROBERTSON, C. S. THAM & H. C. FIBIGER. 1990. Eur. J. Pharmacol. 186:335-338.
11. DAMSMA, G., G. S. ROBERTSON, C. S. THAM & H. C. FIBIGER. 1991. J. Pharmacol. Exp. Therap. 259:1064-1072.
12. LEVIN, E. D. & J. E. ROSE. 1991. Pharmacol. Biochem. Behav. 38:243-246.
13. SCHNEIDER, J. S., Z. Q. SUN & D. P. ROELTGEN. 1994. Brain Res. 663: 140-141.
14. ARNSTEN, A. F. T., X. T. CAI, B. L. MURPHY & P. S. GOLDMAN-RAKIC. 1994. Psychopharmacology 116:143-151.